This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08031/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08031/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08031/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08031/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08031/identifier/pdb/

Statements

Subject Item
n2:DB08031
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB08031 n14:DB08031
dcterms:title
N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE
adms:identifier
n6:JTP n7:99444502 n8:11987832 n10:10160305 n11:DB08031
n3:IUPAC-Name
n4:271B5731-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5737-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5736-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5733-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5734-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5735-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B572F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B572D-363D-11E5-9242-09173F13E4C5 n4:271B5730-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B572E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B573D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B573E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5738-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5739-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B573B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B573A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B573C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5743-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5745-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5746-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5742-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5741-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5744-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5732-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B573F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5740-363D-11E5-9242-09173F13E4C5